Newswise -- The increase in severe outbreaks of gastroenteritis in 2002, including the notorious outbreaks on U.S. cruise ships -- were probably a result of a new variant of norovirus, conclude authors of a study in this week's issue of The Lancet.
Ben Lopman from the UK Health Protection Agency and European colleagues analyzed data collected through a collaborative research and surveillance network of viral gastroenteritis in 10 European countries. Data were compiled based on the number of outbreaks per month during 2002, and genetic sequences from the isolated viruses were compared. Comparisons were also made with historic data from a retrospective review of surveillance systems and with a central database of viral sequences.
In England, Germany, and the Netherlands, there was a striking increase in norovirus outbreaks in 2002 that coincided with the detection and emergence of a new norovirus variant (of genogroup II4), which had a consistent mutation in the polymerase gene. Detection of the new variant preceded an unusual spring and summer peak of outbreaks in three countries (Germany, Netherlands, and Finland).
Lopman comments, "Our combined data from ten European countries shows that the striking increase and unusual seasonal pattern of norovirus gastroenteritis in 2002 arose concurrently with the emergence of a new virus variant. Had these observations been made in one country they could be dismissed as aberrations in surveillance, the result of changes in ecological circumstances, or because of the local circulation of a new variant. However, the data collected within our network lend support to anecdotal reports of an increase of an important infection and have allowed us to present a feasible virological explanation for the effect on public health."
Source: The Lancet.
Expanded Screening Protocols Improve Early Detection of Candida auris at Mount Sinai Brooklyn
December 1st 2024Mount Sinai Brooklyn’s expanded Candida auris screening protocols identified more cases, enabling timely isolation and disinfection measures to prevent outbreaks and enhance patient safety in hospital settings.
Pioneering Advances in Sterilization: The Future of Infection Control
November 28th 2024Germitec, STERIS, ASP, and Zuno Medical are pioneering sterilization advancements with groundbreaking technologies that enhance SPD workflows, improve patient safety, and redefine infection control standards.
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.